Ongeveer 14 resultaten
'Camzyos' anticipated for the DREC review consideration
And the winner is Tirzepatid | PZ ā Pharmazeutische Zeitung
č¾ę²ę³¢åø/č¾ę²ååø(ELTROMBOPAG)ēåøøč§åÆä½ēØå å«åŖäŗļ¼
č¾ä¼å°¼åø/ä¾ē»“ęæå°¼(TIBSOVO)ę²»ēIDH1ēŖåčē®”ēę£č ę¹é¢å±ē°åŗ ā¦
åäø妄åę蓵å?å¤å°é±äøē?-čÆééæ
åäø妄åęäøꬔč½å¤å ē?å¤å°é±?-čÆééæ
ä¼åøęåę(Briumvi)äøäøŖēēØč“¹ēØå¤å°-čÆééæ
ē²åŗčč¼/äøå”å·“č¼(NATULAN)åØę²»ēéå„éę·å·“ē¤ēčæēØäøå ¶åÆ ā¦
150 mg/6 mLēä¼åøęåę(Briumvi)å¤å°é±äøē-čÆééæ
éæé£ę ¼é·ä»æå¶čÆåŖéč½ä¹°å°ļ¼-čÆééæ